Oncogenic mutations of the KRAS gene are observed in ∼40% of sporadic CRC, and up to 90% of these mutations are detected in codons 12 and 13 and less frequently also in codons 61 and 63 (Heinemann et al, 2009). This evidence concerns the gene KRAS and colorectal carcinoma.